rs41313301

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001079802.2(FKTN):ā€‹c.1336A>Gā€‹(p.Asn446Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0104 in 1,614,160 control chromosomes in the GnomAD database, including 163 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0085 ( 12 hom., cov: 32)
Exomes š‘“: 0.011 ( 151 hom. )

Consequence

FKTN
NM_001079802.2 missense

Scores

5
8
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:17

Conservation

PhyloP100: 8.89
Variant links:
Genes affected
FKTN (HGNC:3622): (fukutin) The protein encoded by this gene is a putative transmembrane protein that is localized to the cis-Golgi compartment, where it may be involved in the glycosylation of alpha-dystroglycan in skeletal muscle. The encoded protein is thought to be a glycosyltransferase and could play a role in brain development. Defects in this gene are a cause of Fukuyama-type congenital muscular dystrophy (FCMD), Walker-Warburg syndrome (WWS), limb-girdle muscular dystrophy type 2M (LGMD2M), and dilated cardiomyopathy type 1X (CMD1X). Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Nov 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009369671).
BP6
Variant 9-105635214-A-G is Benign according to our data. Variant chr9-105635214-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 36138.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=4, Uncertain_significance=1, Benign=6}. Variant chr9-105635214-A-G is described in Lovd as [Likely_benign]. Variant chr9-105635214-A-G is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00853 (1299/152318) while in subpopulation SAS AF= 0.0205 (99/4824). AF 95% confidence interval is 0.0173. There are 12 homozygotes in gnomad4. There are 660 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 12 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FKTNNM_001079802.2 linkuse as main transcriptc.1336A>G p.Asn446Asp missense_variant 11/11 ENST00000357998.10 NP_001073270.1 O75072-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FKTNENST00000357998.10 linkuse as main transcriptc.1336A>G p.Asn446Asp missense_variant 11/115 NM_001079802.2 ENSP00000350687.6 O75072-1

Frequencies

GnomAD3 genomes
AF:
0.00853
AC:
1299
AN:
152200
Hom.:
12
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00183
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0112
Gnomad ASJ
AF:
0.0184
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0203
Gnomad FIN
AF:
0.00960
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0111
Gnomad OTH
AF:
0.0120
GnomAD3 exomes
AF:
0.0113
AC:
2841
AN:
251374
Hom.:
29
AF XY:
0.0126
AC XY:
1714
AN XY:
135844
show subpopulations
Gnomad AFR exome
AF:
0.00129
Gnomad AMR exome
AF:
0.00630
Gnomad ASJ exome
AF:
0.0185
Gnomad EAS exome
AF:
0.000109
Gnomad SAS exome
AF:
0.0234
Gnomad FIN exome
AF:
0.00896
Gnomad NFE exome
AF:
0.0127
Gnomad OTH exome
AF:
0.0106
GnomAD4 exome
AF:
0.0106
AC:
15510
AN:
1461842
Hom.:
151
Cov.:
32
AF XY:
0.0112
AC XY:
8179
AN XY:
727222
show subpopulations
Gnomad4 AFR exome
AF:
0.00194
Gnomad4 AMR exome
AF:
0.00711
Gnomad4 ASJ exome
AF:
0.0183
Gnomad4 EAS exome
AF:
0.0000756
Gnomad4 SAS exome
AF:
0.0239
Gnomad4 FIN exome
AF:
0.00786
Gnomad4 NFE exome
AF:
0.0102
Gnomad4 OTH exome
AF:
0.0109
GnomAD4 genome
AF:
0.00853
AC:
1299
AN:
152318
Hom.:
12
Cov.:
32
AF XY:
0.00886
AC XY:
660
AN XY:
74484
show subpopulations
Gnomad4 AFR
AF:
0.00183
Gnomad4 AMR
AF:
0.0112
Gnomad4 ASJ
AF:
0.0184
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.0205
Gnomad4 FIN
AF:
0.00960
Gnomad4 NFE
AF:
0.0111
Gnomad4 OTH
AF:
0.0118
Alfa
AF:
0.0114
Hom.:
23
Bravo
AF:
0.00829
TwinsUK
AF:
0.0102
AC:
38
ALSPAC
AF:
0.00960
AC:
37
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.0124
AC:
107
ExAC
AF:
0.0119
AC:
1443
Asia WGS
AF:
0.00520
AC:
18
AN:
3478
EpiCase
AF:
0.0123
EpiControl
AF:
0.0136

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:17
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:8
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Likely benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoAug 03, 2015- -
Benign, criteria provided, single submitterclinical testingGeneDxJan 17, 2014This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Dec 06, 2012- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsOct 20, 2023- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 26, 2023- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4 Benign:2
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabMay 18, 2021- -
Walker-Warburg congenital muscular dystrophy Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, no assertion criteria providedclinical testingNatera, Inc.Feb 26, 2021- -
Dilated cardiomyopathy 1X Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Cardiomyopathy Benign:1
Benign, no assertion criteria providedclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMay 20, 2015- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJun 29, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.59
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.37
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.76
D;D
Eigen
Pathogenic
0.89
Eigen_PC
Pathogenic
0.87
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.86
.;D
MetaRNN
Benign
0.0094
T;T
MetaSVM
Benign
-0.50
T
MutationAssessor
Uncertain
2.8
M;M
PrimateAI
Uncertain
0.50
T
PROVEAN
Uncertain
-3.6
.;D
REVEL
Uncertain
0.30
Sift
Uncertain
0.012
.;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
1.0
D;D
Vest4
0.58
MPC
0.22
ClinPred
0.020
T
GERP RS
6.0
Varity_R
0.50
gMVP
0.87

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs41313301; hg19: chr9-108397495; API